Skip to main content
Top
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023

23-03-2023 | Mometasone | Original Article

Mometasone Furoate Use for Recurrent Adenoid Hypertrophy: Randomized Controlled Clinical Trial

Authors: Mohamed Mahmoud Roushdy, Ahmed Aboulwafa Abdel jalil, Ahmed Mahmoud Saeed

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 3/2023

Login to get access

Abstract

Background& Objective: Adenoid hypertrophy (AH) in children is one of the most causes of nasal obstruction and is associated with many nasal and respiratory symptoms. Till now, surgery is the main option for managing the associated symptom of AH. The intranasal steroid has an effective role in the control of allergic rhinitis and associated AH. This work aimed to assess the effects of local mometasone on recurrent AH in children. Patients& Methods: A randomized controlled trial enrolled 39 patients aged between 2 and 15 years with recurrent AH. Those patients were randomly subdivided into three groups; group (A) received topical mometasone furoate (MF), group (B) did not receive any medication, and group (C) received topical normal saline. All groups were followed up for 8 weeks. Results: Patients who received Mometasone furoate had temporary relief of adenoid hypertrophy-related symptoms (84.6%) in comparison to the control group and placebo group during the duration of treatment. After cessation of treatment with local steroids, all cases experienced symptoms caused by adenoid hypertrophy, and by the end of the third month of follow up all cases underwent adenoidectomy. Conclusion: Mometasone furoate can temporarily reduce the adenoid size, reducing symptoms related to adenoid hypertrophy.
Literature
1.
go back to reference Scadding G (2010) Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol 21(8):1095–1106CrossRefPubMed Scadding G (2010) Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol 21(8):1095–1106CrossRefPubMed
2.
go back to reference Rutkow IM (1986) Ear, nose, and throat operations in the United States, 1979 to 1984. Archives of Otolaryngology–Head & Neck Surgery 112(8):873–876CrossRef Rutkow IM (1986) Ear, nose, and throat operations in the United States, 1979 to 1984. Archives of Otolaryngology–Head & Neck Surgery 112(8):873–876CrossRef
3.
go back to reference Grundfast KM, Wittich DJ Jr (1982) Adenotonsillar hypertrophy and upper airway obstruction in evolutionary perspective. Laryngoscope 92(6):650–656CrossRefPubMed Grundfast KM, Wittich DJ Jr (1982) Adenotonsillar hypertrophy and upper airway obstruction in evolutionary perspective. Laryngoscope 92(6):650–656CrossRefPubMed
4.
go back to reference Potsic W, Wetmore R (1990) Sleep disorders and airway obstruction in children. Otolaryngol Clin North Am 23(4):651–663CrossRefPubMed Potsic W, Wetmore R (1990) Sleep disorders and airway obstruction in children. Otolaryngol Clin North Am 23(4):651–663CrossRefPubMed
5.
go back to reference Gates GA, Muntz HR, Gaylis B (1992) Adenoidectomy and otitis media. Annals of Otology. Rhinology & Laryngology 101(1suppl):24–32CrossRef Gates GA, Muntz HR, Gaylis B (1992) Adenoidectomy and otitis media. Annals of Otology. Rhinology & Laryngology 101(1suppl):24–32CrossRef
7.
go back to reference Buchinsky FJ, Lowry MA, Isaacson G (2000) Do adenoids regrow after excision? Otolaryngology–Head and Neck Surgery, 123(5): p. 576–581 Buchinsky FJ, Lowry MA, Isaacson G (2000) Do adenoids regrow after excision? Otolaryngology–Head and Neck Surgery, 123(5): p. 576–581
8.
go back to reference Pearl AJ, Manoukian JJ (1994) Adenoidectomy: indirect visualization of choanal adenoids. The J otolaryngology 23(3):221–224 Pearl AJ, Manoukian JJ (1994) Adenoidectomy: indirect visualization of choanal adenoids. The J otolaryngology 23(3):221–224
9.
go back to reference Meltzer EO et al (2010) Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol 105(1):65–74CrossRefPubMed Meltzer EO et al (2010) Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol 105(1):65–74CrossRefPubMed
10.
11.
go back to reference Berlucchi M et al (2007) The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics 119(6):e1392–e1397CrossRefPubMed Berlucchi M et al (2007) The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. Pediatrics 119(6):e1392–e1397CrossRefPubMed
12.
go back to reference Demain JG, Goetz DW (1995) Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 95(3):355–364CrossRefPubMed Demain JG, Goetz DW (1995) Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 95(3):355–364CrossRefPubMed
13.
go back to reference Brouillette RT et al (2001) Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 138(6):838–844CrossRefPubMed Brouillette RT et al (2001) Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 138(6):838–844CrossRefPubMed
14.
go back to reference Criscuoli G et al (2003) Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 111(3):e236–e238CrossRefPubMed Criscuoli G et al (2003) Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 111(3):e236–e238CrossRefPubMed
15.
go back to reference Cengel S, Akyol M (2006) The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol 70(4):639–645CrossRefPubMed Cengel S, Akyol M (2006) The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Pediatr Otorhinolaryngol 70(4):639–645CrossRefPubMed
16.
go back to reference Minshall E et al (1998) Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (nasonex) in the treatment of perennial rhinitis. Otolaryngology-Head and Neck Surgery 118(5):648–654PubMed Minshall E et al (1998) Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (nasonex) in the treatment of perennial rhinitis. Otolaryngology-Head and Neck Surgery 118(5):648–654PubMed
17.
go back to reference Boner AL (2001) Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children. J allergy Clin Immunol 108(1):S32–S39CrossRefPubMed Boner AL (2001) Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children. J allergy Clin Immunol 108(1):S32–S39CrossRefPubMed
18.
go back to reference Schenkel EJ et al (2000) Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 105(2):e22–e22CrossRefPubMed Schenkel EJ et al (2000) Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 105(2):e22–e22CrossRefPubMed
19.
go back to reference Derendorf H, Meltzer E (2008) Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 63(10):1292–1300CrossRefPubMed Derendorf H, Meltzer E (2008) Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 63(10):1292–1300CrossRefPubMed
20.
go back to reference Grindle CR et al (2011) Incidence of revision adenoidectomy in children. Laryngoscope 121(10):2128–2130CrossRefPubMed Grindle CR et al (2011) Incidence of revision adenoidectomy in children. Laryngoscope 121(10):2128–2130CrossRefPubMed
21.
go back to reference Hashemian F, Shahriari H, Ahmadi A, Bikmoradi (2017) Recurrence of adenoid hypertrophy after Adenoidectomy, its Predisposing and Associated factors in children under 15 years referred to Besat Hospital, Hamadan, Iran. Avicenna J Clin Med 24(2):152–157CrossRef Hashemian F, Shahriari H, Ahmadi A, Bikmoradi (2017) Recurrence of adenoid hypertrophy after Adenoidectomy, its Predisposing and Associated factors in children under 15 years referred to Besat Hospital, Hamadan, Iran. Avicenna J Clin Med 24(2):152–157CrossRef
22.
go back to reference Clemens J, McMurray JS, Willging JP (1998) Electrocautery versus curette adenoidectomy: comparison of postoperative results. Int J Pediatr Otorhinolaryngol 43(2):115–122CrossRefPubMed Clemens J, McMurray JS, Willging JP (1998) Electrocautery versus curette adenoidectomy: comparison of postoperative results. Int J Pediatr Otorhinolaryngol 43(2):115–122CrossRefPubMed
23.
go back to reference Lesinskas E, Drigotas M (2009) The incidence of adenoidal regrowth after adenoidectomy and its effect on persistent nasal symptoms. Eur Arch Otorhinolaryngol 266(4):469–473CrossRefPubMed Lesinskas E, Drigotas M (2009) The incidence of adenoidal regrowth after adenoidectomy and its effect on persistent nasal symptoms. Eur Arch Otorhinolaryngol 266(4):469–473CrossRefPubMed
24.
go back to reference Bhargava R, Chakravarti A (2014) Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children. J Laryngol Otol 128(12):1060CrossRefPubMed Bhargava R, Chakravarti A (2014) Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children. J Laryngol Otol 128(12):1060CrossRefPubMed
25.
go back to reference Mohebbi S et al (2014) Assessment of Intranasal Steroid Effect in Management of Adenoid Hypertrophy in children between 2–11 Years Old. J Pharm Pharmacol 2:211–217 Mohebbi S et al (2014) Assessment of Intranasal Steroid Effect in Management of Adenoid Hypertrophy in children between 2–11 Years Old. J Pharm Pharmacol 2:211–217
26.
go back to reference Demirhan H et al (2010) Medical treatment of adenoid hypertrophy with “fluticasone propionate nasal drops”. Int J Pediatr Otorhinolaryngol 74(7):773–776CrossRefPubMed Demirhan H et al (2010) Medical treatment of adenoid hypertrophy with “fluticasone propionate nasal drops”. Int J Pediatr Otorhinolaryngol 74(7):773–776CrossRefPubMed
27.
go back to reference Hassan FM (2014) Medical treatment of adenoid hypertrophy with mometasone furoate monohydrate nasal spray. kufa J Nurs Sci 4(2):153–159 Hassan FM (2014) Medical treatment of adenoid hypertrophy with mometasone furoate monohydrate nasal spray. kufa J Nurs Sci 4(2):153–159
28.
go back to reference Yildirim YS et al (2016) Efficacy of nasal corticosteroid in preventing regrowth after adenoidectomy. Auris Nasus Larynx 43(6):637–640CrossRefPubMed Yildirim YS et al (2016) Efficacy of nasal corticosteroid in preventing regrowth after adenoidectomy. Auris Nasus Larynx 43(6):637–640CrossRefPubMed
29.
go back to reference Rezende RM et al (2012) Objective reduction in adenoid tissue after mometasone furoate treatment. Int J Pediatr Otorhinolaryngol 76(6):829–831CrossRefPubMed Rezende RM et al (2012) Objective reduction in adenoid tissue after mometasone furoate treatment. Int J Pediatr Otorhinolaryngol 76(6):829–831CrossRefPubMed
30.
go back to reference Pufall MA Glucocorticoids and Cancer. Advances in experimental medicine and biology, 2015. 872: p. 315–333 Pufall MA Glucocorticoids and Cancer. Advances in experimental medicine and biology, 2015. 872: p. 315–333
31.
go back to reference Tuhanıoğlu B, Erkan SO (2017) Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data. Turk J Med Sci 47(6):1736–1743CrossRefPubMed Tuhanıoğlu B, Erkan SO (2017) Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data. Turk J Med Sci 47(6):1736–1743CrossRefPubMed
Metadata
Title
Mometasone Furoate Use for Recurrent Adenoid Hypertrophy: Randomized Controlled Clinical Trial
Authors
Mohamed Mahmoud Roushdy
Ahmed Aboulwafa Abdel jalil
Ahmed Mahmoud Saeed
Publication date
23-03-2023
Publisher
Springer India
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 3/2023
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-03539-1

Other articles of this Issue 3/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023 Go to the issue